Author

Malin Wickström

Karolinska InstitutetORCID 0000-0001-5214-9956Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Approach:benchmark study· 1 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1

Frequent Co-Authors

John Inge JohnseniD· 2 shared Alena MalyukovaiD· 1 shared Alessandro Simone BordonaroiD· 1 shared Andrä BrunneriD· 1 shared Cecilia H. Dyberg· 1 shared Conny TümmleriD· 1 shared Dimitrios TsagkogiannisiD· 1 shared Ervelina Dalani· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

John Inge JohnsenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 29, 2026

Circadian gene-network distortion in high-risk neuroblastoma across multiple biological reference contexts

N Maussier, Dimitrios Tsagkogiannis, N. Baryawno…·Tomas Sjöberg Bexelius

This study identifies circadian gene network disruption in high-risk neuroblastoma across multiple biological contexts, showing it is a network-level alteration rather than a single-gene effect.

DOI 10.64898/2026.09.28.754955

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 31, 2026

Targeting the FBXL12-FANCD2 Pathway Disrupts Replication Stress Tolerance in MYCN-Driven Neuroblastoma

Jinjiang Chou, Alena Malyukova, Alessandro Simone Bordonaro…·Olle Sangfelt

This study identifies the FBXL12-FANCD2 pathway as a vulnerability in MYCN-driven neuroblastoma, showing its role in replication stress tolerance and potential as a therapeutic target.

DOI 10.64898/2026.08.29.745966

humanbulk RNA-seq

𝕏 PostBluesky